B+
Bull case
25%
Probability
Target price
$74.00
-16.0% vs current
BHE
Benchmark ElectronicsBNYSE / Technology Hardware & Equipment
Last Price
At close
2026-06-02
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
50%
Probability
Target price
$62.00
-29.7% vs current
B-
Bear case
25%
Probability
Target price
$55.00
-37.6% vs current
AI sentiment snapshot
Latest data as of 2026-04-29
Recent news sentiment (30D)
+6.6
Positive
Company
+17.2
Positive
Macro
+7.9
Positive
Pulse
-35.0
Negative
Sentiment proxy
+20.0
Score
AI commentary
Headline flow is modestly active because of the April 15 scheduling notice and March 16 dividend announcement, but this is still a monitoring setup: the company scheduled results for after market close on April 29, 2026, and immediate earnings surprise, analyst revisions, and post-release market reaction were not yet available at the time of this run. That lack of post-print evidence should be treated as an uncertainty, not as positive confirmation.
RankAlpha Sentiment Codex - 2026-04-29
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-04-29eventQ1 2026 earnings release is the near-term gating eventHigh impact
Benchmark said it would report first-quarter 2026 results after the market close on April 29, 2026, and prior company materials framed Q1/fiscal 2026 outlook as a key forward-looking item; as of this run, an earnings 8-K/release was not yet confirmed in recent SEC submissions, so the thesis remains pre-print monitoring rather than post-print conviction [#10-K-2026-02-24].
2026-05-15catalystDividend/capital-return signal is supportive but likely mostly pricedMedium impact
Benchmark declared a quarterly cash dividend of $0.17 per share, payable April 10, 2026, which supports a cash-generation and shareholder-return narrative, but by itself is unlikely to offset an earnings miss or weaker guide [#8-K-2026-03-16].
2026-07-29catalystSemi-cap-heavy mix can support upside if bookings and utilization holdMedium impact
Benchmark's 2025 sales mix was led by Semi-Cap at 28%, followed by Industrial at 22%, A&D at 19%, and Medical at 18%; if that mix continues to drive bookings and plant utilization, the company has a path to steadier growth, but the same filing warns that under-utilization, excess inventory write-downs, tariffs, and retaliatory countermeasures can impair results [#10-K-2026-02-24].
Recommendation
N/A
No formal recommendation provided.
As of 2026-04-29 • Updated nightlySource: Internal modelMethodology